期刊文献+

阿昔洛韦缓释片的制备及体外释药的研究 被引量:4

Study on the preparation and in vitro release of sustained release acyclovir hydrophilic matrix tablets
暂未订购
导出
摘要   目的:研制凝胶骨架型阿昔洛韦缓释片,考察缓释片的体外释药特性。方法:以羟丙甲纤维素为主要凝胶材料,采用正交 设计,根据体外释药速率优选处方。结果:缓释片在10h内缓慢释药,其体外释药速率符合Higuchi方程,释药速度主要受到HPMC 的类型、用量的影响,但压片压力的影响较小。 Objective: To prepare and study Materia Medica the in vitro release of sustained release acylovir hydrophilic matrix tablets. Method: Using hypromellose( HMPC) as the main gel additive the formulation was optimizedaccording to the result of in vitro release rate based on orthogonal design. Conclusion: Sustained release acyclovir hydrophilic matrix tablets was released gradually within 10 hours in good accordance with the Higuchi equation. The release rate was mainly affected by types and amount of HPMC,with minor effect from compression pressure.
出处 《广东药学院学报》 CAS 2002年第4期263-265,共3页 Academic Journal of Guangdong College of Pharmacy
关键词 制备 阿昔洛韦 缓释片 释放度 HPMC acyclovir sustained release tablets release rate HMPC
  • 相关文献

参考文献6

  • 1张维江,于红.抗病毒药物的临床应用及其副作用[J].中国综合临床,2001,17(10):733-734. 被引量:14
  • 2Vergin H, Kikuta C, Mascher H, et al. Pharmacokinetics and bioavailability of different formulations of aciclovir [ J ]. Drug Res, 1995,45(1 ) :508.
  • 3Lewis LD, Fovle ASE, Bittiner SB, et al. Human gastrintestinal absorption of acyclovir from tablets duodenal infusion and sipped solution [ J ]. Br J Clin Pharmacol, 1986,21:459.
  • 4王志刚.HPMC质量剖析与评价[J].中国医药工业杂志,1996,3:9-9.
  • 5苏杰,张钧寿,吴葆金.亲水凝胶在药物制剂中的应用[J].药学进展,1999,23(3):143-147. 被引量:11
  • 6倪永兴.多指标试验公式评分法和综合比较法探讨[J].应用概率统计,1988,4(1):85-85.

二级参考文献6

共引文献27

同被引文献17

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部